These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cerebrospinal fluid biochemical markers in central nervous system tumors: a review. Wasserstrom WR; Schwartz MK; Fleisher M; Posner JB Ann Clin Lab Sci; 1981; 11(3):239-51. PubMed ID: 6166240 [No Abstract] [Full Text] [Related]
3. Assessment of tumor markers in cerebrospinal fluid. Jaeckle KA Clin Lab Med; 1985 Jun; 5(2):303-15. PubMed ID: 2411459 [TBL] [Abstract][Full Text] [Related]
4. Biochemical markers of central nervous system tumors measured in cerebrospinal fluid and their potential use in diagnosis and patient management: a review. Seidenfeld J; Marton LJ J Natl Cancer Inst; 1979 Oct; 63(4):919-31. PubMed ID: 384010 [TBL] [Abstract][Full Text] [Related]
5. Biochemical markers of central nervous system tumors in cerebrospinal fluid. Seidenfeld J; Marton LJ Ann Clin Lab Sci; 1978; 8(6):459-66. PubMed ID: 736510 [No Abstract] [Full Text] [Related]
6. [Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis]. Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T No Shinkei Geka; 1991 Dec; 19(12):1135-41. PubMed ID: 1766538 [TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid and serum carcinoembryonic antigen in brain tumors. Batabyal SK; Ghosh B; Sengupta S; Ghosh SN; Chatterjee R Neoplasma; 2003; 50(5):377-9. PubMed ID: 14628092 [TBL] [Abstract][Full Text] [Related]
9. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors. Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946 [TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid carcinoembryonic antigen and alphafetoprotein in patients with central nervous system neoplasia. Rombos A; Evangelopoulu-Katsiri E; Mariatos P; Katsouyanni K; Papagegorgiou C Acta Neurol Scand; 1988 Jun; 77(6):440-4. PubMed ID: 2457289 [TBL] [Abstract][Full Text] [Related]
11. [Importance of cerebrospinal fluid spectrophotometry for the differential diagnosis of central nervous system tumors]. Shevaga VN; Andriiuk LV; Besedin VN; Zastavnaia ; Romaniuk RG Vrach Delo; 1987 Sep; (9):82-4. PubMed ID: 3424783 [No Abstract] [Full Text] [Related]
12. Cerebrospinal fluid biochemical markers of central nervous system metastases. Schold SC; Wasserstrom WR; Fleisher M; Schwartz MK; Posner JB Ann Neurol; 1980 Dec; 8(6):597-604. PubMed ID: 7212647 [TBL] [Abstract][Full Text] [Related]
13. Selected ion monitoring technique for the evaluation of sterols in cerebrospinal fluid: a new approach to desmosterol test for central nervous system tumors. Bernini F; Sangiovanni G; Pezzotta S; Galli G; Fumagalli R; Paoletti P J Neurooncol; 1986; 4(1):31-5. PubMed ID: 3746383 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid sterols in the evaluation of patients with gliomas. Ransohoff J; Weiss J Natl Cancer Inst Monogr; 1977 Dec; 46():119-24. PubMed ID: 613222 [TBL] [Abstract][Full Text] [Related]
15. [The level of embryonic antigens in the blood serum and cerebrospinal fluid of neuro-oncological patients]. Rudenko VA; Lisianyĭ NI; Grinevich IuA; Burkatovskaia MB; Iugrinova LG Zh Vopr Neirokhir Im N N Burdenko; 1996; (3):32-5. PubMed ID: 8975514 [TBL] [Abstract][Full Text] [Related]